Limitations stated clinical research in humans is described as "limited" and unapproved status is named clearly
How much bacteriostatic water for a 20 mg peptide
Theres no one-size-fits-all
The FDA evaluation found insufficient evidence to establish effectiveness for the nominated use and highlighted gaps in physicochemical characterisation, immunogenicity and safety information
Sikiric is named on BPC-157-related patent applications dating back to at least 1989, and Croatian government records list Predrag Sikiric as an owner of PharmaCotherapia, the company that sponsored the Tijuana trial
Heise T, Devries JH, Urva S, Li J, Pratt EJ, Thomas MK, et al